Literature DB >> 187095

Naloxone.

W R Martin.   

Abstract

Narcotic analgesics and related drugs act as agonists on several receptors that are responsible for their effects on pain perception, mood and feeling state, and respiration, as well as other pharmacologic actions. Naloxone is the first discovered antagonist that is devoid of agonistic activity and appears to be a competitive antagonist at several receptors. The ability of naloxone to displace or prevent the binding of agonistic narcotics is partly responsible for its antagonistic effects. The ability of naloxone to rectify narcotic-depressed homeostats and precipitate abstinence is also related to its antagonistic activity. Certain cautions and principles apply in the use of naloxone in treating narcotic overdose, reversing surgical analgesia, and the treatment of neonates and children. Unapproved uses of naloxine include reversing the psychotomimetic effects of certain agonists-antagonists, terminating narcotic-induced convulsions and coma, reversing non-narcotic depression, diagnosing physical dependence, and treating narcotic addicts.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 187095     DOI: 10.7326/0003-4819-85-6-765

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  20 in total

1.  Relationship between endogenous opioid function and opioid analgesic adverse effects.

Authors:  Rajnish K Gupta; Stephen Bruehl; John W Burns; Asokumar Buvanendran; Melissa Chont; Erik Schuster; Christopher R France
Journal:  Reg Anesth Pain Med       Date:  2014 May-Jun       Impact factor: 6.288

2.  Emergency medicine-important advances in clinical medicine: naloxone-new uses?

Authors:  D A Guss; R J Rothstein
Journal:  West J Med       Date:  1983-01

Review 3.  Clinical applications of commonly used contemporary antidotes. A US perspective.

Authors:  C A Bowden; E P Krenzelok
Journal:  Drug Saf       Date:  1997-01       Impact factor: 5.606

4.  Endogenous Opioid Function and Responses to Morphine: The Moderating Effects of Anger Expressiveness.

Authors:  John W Burns; Stephen Bruehl; Christopher R France; Erik Schuster; Daria Orlowska; Melissa Chont; Rajnish K Gupta; Asokumar Buvanendran
Journal:  J Pain       Date:  2017-03-30       Impact factor: 5.820

5.  Nonspecific arousal with noloxone.

Authors:  F N Finkelstein; L H Bayne; R E Rangno
Journal:  Can Med Assoc J       Date:  1980-07-05       Impact factor: 8.262

6.  Naloxone in treatment of circulatory shock resistant to conventional therapy.

Authors:  B Allolio; H Fischer; D Kaulen; U Deuss; W Winkelmann
Journal:  Klin Wochenschr       Date:  1987-03-02

7.  Endogenous opioid inhibition of chronic low-back pain influences degree of back pain relief after morphine administration.

Authors:  Stephen Bruehl; John W Burns; Rajnish Gupta; Asokumar Buvanendran; Melissa Chont; Erik Schuster; Christopher R France
Journal:  Reg Anesth Pain Med       Date:  2014 Mar-Apr       Impact factor: 6.288

8.  Case files of the University of Massachusetts fellowship in medical toxicology: lethal dose of opioids contained in an elastomeric capsule labeled as vancomycin.

Authors:  James Courtney; Edward Boyer
Journal:  J Med Toxicol       Date:  2008-09

9.  Effect of an opiate antagonist (naloxone) on the gastric acid secretory response to sham feeding, pentagastrin, and histamine in man.

Authors:  M Feldman; Y M Cowley
Journal:  Dig Dis Sci       Date:  1982-04       Impact factor: 3.199

10.  Failure of naloxone to antagonize metoclopramide induced prolactin rise.

Authors:  L Laurian; Z Oberman; D Ayalon; E Graf; A Fitermann; E Hoerer
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.